Biofrontera Warrants Company Insiders
| BFRIW Stock | USD 0.09 0.01 12.22% |
Biofrontera Warrants employs about 83 people. The company is managed by 7 executives with a total tenure of roughly 194 years, averaging almost 27.0 years of service per executive, having 11.86 employees per reported executive. Recap of Biofrontera Warrants' management performance can provide insight into the venture performance.
Biofrontera |
Biofrontera Warrants Management Team Effectiveness
The company has return on total asset (ROA) of (0.4024) % which means that it has lost $0.4024 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4941) %, meaning that it generated substantial loss on money invested by shareholders. Biofrontera Warrants' management efficiency ratios could be used to measure how well Biofrontera Warrants manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.84 in 2024. Return On Capital Employed is likely to climb to -2.19 in 2024. At this time, Biofrontera Warrants' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 6.4 M in 2024, whereas Other Current Assets are likely to drop slightly above 4.7 M in 2024.Common Stock Shares Outstanding is likely to drop to about 1 M in 2024
Biofrontera Warrants Workforce Comparison
Biofrontera Warrants is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 221. Biofrontera Warrants totals roughly 83.0 in number of employees claiming about 38% of equities under Health Care industry.
Biofrontera Warrants Profit Margins
The company has Profit Margin (PM) of (0.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.54 | 0.488 |
|
|
Biofrontera Warrants Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biofrontera Warrants insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biofrontera Warrants' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biofrontera Warrants insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lanckriet Heikki over a month ago Insider Trading |
Biofrontera Warrants Notable Stakeholders
A Biofrontera Warrants stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biofrontera Warrants often face trade-offs trying to please all of them. Biofrontera Warrants' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biofrontera Warrants' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hermann Luebbert | President CEO | Profile | |
| Jon MBA | Vice Affairs | Profile | |
| Daniel JD | General Compliance | Profile | |
| Mark Baldyga | Vice Marketing | Profile | |
| Alycia Torres | Vice Administration | Profile | |
| Samantha Widdicombe | Senior Communications | Profile | |
| Eugene III | Chief Officer | Profile |
About Biofrontera Warrants Management Performance
The success or failure of an entity such as Biofrontera Warrants often depends on how effective the management is. Biofrontera Warrants management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biofrontera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biofrontera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.80) | (0.84) | |
| Return On Capital Employed | (2.30) | (2.19) | |
| Return On Assets | (0.72) | (0.76) | |
| Return On Equity | (4.20) | (3.99) |
Please note, the imprecision that can be found in Biofrontera Warrants' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biofrontera Warrants. Check Biofrontera Warrants' Beneish M Score to see the likelihood of Biofrontera Warrants' management manipulating its earnings.
Biofrontera Warrants Workforce Analysis
Traditionally, organizations such as Biofrontera Warrants use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biofrontera Warrants within its industry.Biofrontera Warrants Manpower Efficiency
Return on Biofrontera Warrants Manpower
| Revenue Per Employee | 410.5K | |
| Revenue Per Executive | 4.9M | |
| Net Loss Per Employee | 242.5K | |
| Net Loss Per Executive | 2.9M | |
| Working Capital Per Employee | 60.1K | |
| Working Capital Per Executive | 712.4K |
Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.